Post by
alleyesonme on Jan 08, 2024 3:04pm
Mr Strachan on X..
S1i...wow.."hurry up FDA" agree this says it all....global pharma partner expecting FDA approval...or clinical trial approval...explosive comments...he probably shouldn't of said anything..nevertheless, patiently wait we will...meanwhile dronabinol generic ready for Germany..ANVISA approval/shipments expected this quarter, possibly a new pharmaceutical..meanwhile DEA rescheduling announcement imminent..Canadian cannabis review, final report due for House of Commons/senate by March.....3m additional annualized savings commenced Q3....Y/E,Q4 out March including sales without shelter royalties, higher margin German flower sales, and new high demand vapes, distillates and flower for the tighter Australian market to name a few...dang.